IN2012DN00968A - - Google Patents
Info
- Publication number
- IN2012DN00968A IN2012DN00968A IN968DEN2012A IN2012DN00968A IN 2012DN00968 A IN2012DN00968 A IN 2012DN00968A IN 968DEN2012 A IN968DEN2012 A IN 968DEN2012A IN 2012DN00968 A IN2012DN00968 A IN 2012DN00968A
- Authority
- IN
- India
- Prior art keywords
- tiotropium bromide
- anhydrous tiotropium
- novel
- compositions
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Abstract
Novel Anhydrate The present invention relates to a novel form of anhydrous tiotropium bromide, processes for the preparation of anhydrous tiotropium bromide, pharmaceutical compositions comprising anhydrous tiotropium bromide and uses of the compositions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN968DEN2012 IN2012DN00968A (en) | 2009-08-07 | 2010-08-06 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1048KO2009 | 2009-08-07 | ||
PCT/GB2010/051310 WO2011015882A2 (en) | 2009-08-07 | 2010-08-06 | Novel anhydrate |
IN968DEN2012 IN2012DN00968A (en) | 2009-08-07 | 2010-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00968A true IN2012DN00968A (en) | 2015-04-10 |
Family
ID=42830336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN968DEN2012 IN2012DN00968A (en) | 2009-08-07 | 2010-08-06 |
Country Status (9)
Country | Link |
---|---|
US (2) | US8697719B2 (en) |
EP (1) | EP2462140A2 (en) |
JP (2) | JP5822831B2 (en) |
CN (1) | CN102639531B (en) |
AU (1) | AU2010280497B2 (en) |
CA (2) | CA2931876A1 (en) |
IN (1) | IN2012DN00968A (en) |
NZ (2) | NZ597920A (en) |
WO (1) | WO2011015882A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102731494A (en) | 2005-12-19 | 2012-10-17 | 西科尔公司 | Novel forms of tiotropium bromide and processes for preparation thereof |
US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
JP5822831B2 (en) | 2009-08-07 | 2015-11-24 | ジェネリクス・[ユーケー]・リミテッド | Tiotropium bromide anhydride |
TR201111589A2 (en) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropium bromide anhydrous crystal form. |
PT106142B (en) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | PROCESS FOR THE PREPARATION OF TIOTROPE BROMIDE |
WO2014042605A1 (en) * | 2012-09-11 | 2014-03-20 | Mahmut Bilgic | New tiotropium bromide crystalline form |
CN104341413A (en) * | 2013-07-29 | 2015-02-11 | 天津金耀集团有限公司 | Anhydrous tiotropium bromide new crystal form |
PL2897588T3 (en) * | 2013-11-22 | 2019-12-31 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
EP2913332A1 (en) | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
EA201990605A1 (en) * | 2016-10-14 | 2019-10-31 | SPRAYED THIOTROPY AND FORMOTEROL COMPOSITIONS |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
DE3931041C2 (en) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
ME00243B (en) | 2000-10-12 | 2011-05-10 | Boehringer Ingelheim Pharma | Crystalline monohydrate of tiotropiumbromide, method for producing the same and the use thereof in the production of a medicament |
DE10064816A1 (en) | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Production of tiotropium bromide useful as an anticholinergic comprises oxidation of di-(2-thienyl)-glycolic acid tropenol ester and subsequent quaternisation |
US6506900B1 (en) | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
AUPR315301A0 (en) | 2001-02-19 | 2001-03-15 | Silverbrook Research Pty. Ltd. | An Apparatus (ART102) |
US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
US6610849B2 (en) | 2001-06-28 | 2003-08-26 | Boehringer Ingelheim Pharma Kg | Process for the manufacture of tropenol |
DE10200943A1 (en) | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Process for the preparation of scopine esters |
US6747153B2 (en) | 2002-05-31 | 2004-06-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Industrial process for preparing tropenol |
ATE435862T1 (en) | 2003-05-28 | 2009-07-15 | Theravance Inc | AZABICYCLOALKAN COMPOUNDS AS MUSCARINE RECEPTOR ANTAGONISTS |
PL1682542T3 (en) | 2003-11-03 | 2010-06-30 | Boehringer Ingelheim Int | Novel crystalline anhydride with anticholinergic effect |
US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
CN1271073C (en) * | 2004-10-26 | 2006-08-23 | 江苏正大天晴药业股份有限公司 | Crystalline anti-cholinergic tiotropium crystal |
WO2006076222A2 (en) | 2005-01-10 | 2006-07-20 | Glaxo Group Limited | Pharmaceutical formulations |
AU2006243238B2 (en) | 2005-05-02 | 2012-05-24 | Boehringer Ingelheim International Gmbh | Novel crystalline forms of tiotropium bromide |
RU2007144531A (en) * | 2005-05-02 | 2009-06-10 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | NEW CRYSTAL FORMS OF THIOTROPYBROMIDE |
DE102005035112A1 (en) | 2005-07-27 | 2007-02-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | A new process for the preparation of tiotropium salts using N-methylscopinium salts soluble in organic solvents |
US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
WO2007075838A2 (en) * | 2005-12-19 | 2007-07-05 | Sicor Inc. | Pure and stable tiotropium bromide |
CN102731494A (en) * | 2005-12-19 | 2012-10-17 | 西科尔公司 | Novel forms of tiotropium bromide and processes for preparation thereof |
CN100410254C (en) * | 2006-03-07 | 2008-08-13 | 南昌弘益科技有限公司 | Preparation process of thiatro bromoaminium anhydrous compound |
US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
WO2008089852A1 (en) | 2007-01-26 | 2008-07-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Novel process for preparing tiotropium salts |
PL2120936T3 (en) | 2007-02-21 | 2011-11-30 | Almirall Sa | Novel methods |
WO2008104955A1 (en) | 2007-02-28 | 2008-09-04 | Ranbaxy Laboratories Limited | Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists |
CN101918401A (en) | 2008-01-10 | 2010-12-15 | 基因里克斯(英国)有限公司 | Novel process for the preparation of scopine esters |
WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
WO2011015884A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Process to prepare scopine esters |
JP5822831B2 (en) | 2009-08-07 | 2015-11-24 | ジェネリクス・[ユーケー]・リミテッド | Tiotropium bromide anhydride |
WO2011095800A2 (en) | 2010-02-02 | 2011-08-11 | Generics [Uk] Limited | Analytical methods |
-
2010
- 2010-08-06 JP JP2012523394A patent/JP5822831B2/en not_active Expired - Fee Related
- 2010-08-06 US US13/386,550 patent/US8697719B2/en not_active Expired - Fee Related
- 2010-08-06 WO PCT/GB2010/051310 patent/WO2011015882A2/en active Application Filing
- 2010-08-06 IN IN968DEN2012 patent/IN2012DN00968A/en unknown
- 2010-08-06 NZ NZ597920A patent/NZ597920A/en not_active IP Right Cessation
- 2010-08-06 CN CN201080044044.4A patent/CN102639531B/en not_active Expired - Fee Related
- 2010-08-06 AU AU2010280497A patent/AU2010280497B2/en not_active Ceased
- 2010-08-06 EP EP10743206.4A patent/EP2462140A2/en not_active Ceased
- 2010-08-06 NZ NZ624602A patent/NZ624602A/en not_active IP Right Cessation
- 2010-08-06 CA CA2931876A patent/CA2931876A1/en not_active Abandoned
- 2010-08-06 CA CA2768553A patent/CA2768553C/en not_active Expired - Fee Related
-
2014
- 2014-04-07 US US14/246,291 patent/US9181268B2/en active Active
-
2015
- 2015-08-05 JP JP2015155158A patent/JP2015214574A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US9181268B2 (en) | 2015-11-10 |
CN102639531A (en) | 2012-08-15 |
JP2015214574A (en) | 2015-12-03 |
AU2010280497A1 (en) | 2012-02-23 |
CA2768553A1 (en) | 2011-02-10 |
JP2013501041A (en) | 2013-01-10 |
WO2011015882A2 (en) | 2011-02-10 |
WO2011015882A3 (en) | 2011-09-01 |
CN102639531B (en) | 2016-01-20 |
US20120149725A1 (en) | 2012-06-14 |
CA2931876A1 (en) | 2011-02-10 |
CA2768553C (en) | 2016-08-02 |
NZ624602A (en) | 2015-11-27 |
NZ597920A (en) | 2014-05-30 |
AU2010280497A8 (en) | 2012-03-08 |
US8697719B2 (en) | 2014-04-15 |
US20140249175A1 (en) | 2014-09-04 |
JP5822831B2 (en) | 2015-11-24 |
EP2462140A2 (en) | 2012-06-13 |
AU2010280497B2 (en) | 2015-10-22 |
US20150051241A9 (en) | 2015-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00968A (en) | ||
JOP20180102B1 (en) | Pharmaceutical composition | |
MD20150091A2 (en) | Anti-viral compounds | |
TN2014000030A1 (en) | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators | |
MX2010007587A (en) | Compounds comprising a cyclobutoxy group. | |
MX2011008864A (en) | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products. | |
MX2020011251A (en) | Antiviral compounds. | |
WO2012088038A3 (en) | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof | |
MY187718A (en) | Pharmaceutical formulations | |
WO2012088124A3 (en) | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof | |
MX2013000793A (en) | Galacto-oligosaccharide-containing composition and a method of producing it. | |
WO2010150211A3 (en) | Use of derivatives of indoles for the treatment of cancer | |
MX2014002625A (en) | Novel compositions for producing cast polyamides. | |
IN2012DN01292A (en) | ||
WO2013114400A3 (en) | Compressed pharmaceutical compositions of atypical antipsychotics | |
MX2012010443A (en) | Process for the preparation of 5-substituted 1-alkyltetrazoles. | |
WO2012063115A3 (en) | Process for the preparation of rosuvastatin calcium via novel amine intermediate | |
IN2014DN03245A (en) | ||
MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
EP2568810A4 (en) | Darunavir compositions | |
TR201002878A2 (en) | Pharmaceutical compositions comprising cefpodoxime proxetil. | |
MX2011008126A (en) | Substituted indole compounds as bradykinin receptor 1 modulators. | |
GEP20156269B (en) | New secondary 8-hydroxyquinoline-7- carboxamide derivatives | |
TR201009166A2 (en) | Production method for cefdinir-containing pharmaceutical composition | |
WO2011128699A3 (en) | Novel process for the preparation of sunitinib |